Giuseppe Cicala

12PUBLICATIONS
27CO-AUTHORS
Molecular medicinePharmacogenomicsPoverty, inclusivity and wellbeingGene and molecular therapyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 26, 2026
Safety Profile of Zavegepant in the Treatment of Acute Migraine: Insights from the FDA Adverse Event Monitoring System Database.

|Jun 02, 2026
Exploring the Influence of Inflammation on the Pharmacokinetics of Antidepressants and Antipsychotics: A Systematic Review.

|Apr 02, 2026
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy.

Maria Antonietta Barbieri, Giuseppe Cicala, Antonino Molonia

|Mar 17, 2025
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System.

Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala

|Oct 26, 2024
Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database.

Giuseppe Cicala, Michelangelo Rottura, Viviana Maria Gianguzzo

|Oct 26, 2024
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System.

Giuseppe Cicala, Giulia Russo, Vincenza Santoro

Pageof 2

Frequent Collaborators

11 joint publications

Maria Antonietta Barbieri

10 joint publications

Edoardo Spina

4 joint publications

Giulia Russo

2 joint publications

Giovanni Pallio